NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Survivorship

ImpediMed Launches Imp SFB7 in US on 1st December

ImpediMed’s SFB7, a bioimpedance spectroscopy (BIS) instrument is now FDA cleared for body composition assessment and available in the US and Canada.

The ultimate in bioimpedance technology for body composition assessment. Fast. Accurate. Portable. The SFB7 reads across 256 frequencies in less than a second. Total testing time including set up is less than three minutes. BIS technology means the SFB7 doesn’t use prediction equations like single frequency BIA. Validation studies confirm ImpediMed’s SFB7 correlates highly with DEXA and reference methods, giving you confidence in your results. And the SFB7 is a completely portable medical device you can use in the office, take into the lab or to the patient bedside, bring to clinics, schools or the workplace.

Finally, a body composition device that meets all your requirements for speed, accuracy and convenience!